Overview

Vladislav Krupalnik is a serial biotech entrepreneur with over 8 years of experience translating cutting- edge academic research into commercial ventures. 

Currently CEO and Co-Founder of RenewalBio Ltd., he specializes in regenerative medicine, advanced therapy development, and innovation management. His expertise spans regenerative medicine, stem cell biology, cellular therapy, bioinformatics, and innovation management. He has contributed to the founding of three biotech companies, securing $40M+ in aggregate funding, with 47 peer-reviewed publications and 4,600 citations. 

Dr. Krupalnik holds a Ph.D. (Direct Track) in Molecular Genetics from Weizmann Institute of Science (thesis: novel embryonic factors promoting pluripotency induction) and a B.Sc. in Biotechnology from Bar-Ilan University.